Track topics on Twitter Track topics that are important to you
Deals and Financings
- OrbiMed closed its third Asia private equity fund with $551 million in capital commitments, bringing its three
- Innovent Biologics of
- 3SBio of
- Eight Roads, Fidelity Investment's venture arm, launched a $250 million China Healthcare Fund, its first fund dedicated to
- WuXi NextCODE completed a Series B fundraising with $240 million in new capital for its genomics CRO operations;
- Sisram Medical, an Israeli subsidiary of Fosun Pharma that makes laser-based aesthetic devices, will stage a $200 million Hong Kong IPO;
- Shanghai Sanyou Medical, an orthopedic medical device maker, closed a $14 million B round from Yingke Private Equity;
- China Medical Systems of Shenzhen will gain
- TPG Capital Asia acquired a majority stake in OPC Holding Company, a
- Wuxi Fortune Pharma partnered with Andarix Pharma of
Stock Symbols: (HK: 1530) (SHA: 600196; HK: 02196) (NYSE: LLY)
Share this with colleagues:
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...